18 studies found for:    weill | Open Studies | "Gastrointestinal Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions: Drug: Azacitidine;   Drug: Oxaliplatin;   Drug: Epirubicin;   Drug: Capecitabine
2 Recruiting Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma
Conditions: Gastric Adenocarcinoma;   Gastroesophageal Adenocarcinoma;   Distal Esophageal Adenocarcinoma
Intervention: Drug: Cabazitaxel
3 Recruiting Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
Condition: Esophageal Cancer
Intervention: Device: HANAROSTENT TM covered Esophageal Stent
4 Unknown  177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer;   Head and Neck Cancer;   Breast Cancer;   Non-small Cell Lung Cancer;   Colorectal Cancer;   Pancreatic Cancer;   Ovarian Cancer;   Esophageal Cancer;   Gliomas
Intervention: Drug: 177Lu-J591
5 Unknown  Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal Cancer
Condition: Rectal Cancer
Interventions: Procedure: HAL proctectomy;   Procedure: "straight" laparoscopic proctectomy;   Procedure: Hand-assisted laparoscopic proctectomy;   Procedure: SL Proctectomy
6 Recruiting Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cancer
Intervention: Other: Neuroimaging & Neuropsychological Evaluation
7 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
8 Recruiting Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma;   Gastric Cancer
Interventions: Drug: Docetaxel, Leucovorin, Fluorouracil, Cisplatin;   Drug: Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen
9 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
10 Recruiting EUS-Guided ERCP Multicenter Registry
Conditions: Cholangiocarcinoma;   Pancreatic Cancer;   Bile Duct Cancer;   Biliary Stricture;   Biliary Obstruction;   Stent Obstruction;   Proximal Duct Stricture;   Distal Duct Stricture;   Ampullary Cancer;   Biliary Sphincter Stenosis;   Impacted Stones;   Chronic Pancreatitis;   Peri-ampullary Diverticula;   Altered Anatomy
Intervention: Procedure: EUS guided ERCP
11 Recruiting Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer
Conditions: Cholangiocarcinoma;   Pancreatic Cancer
Intervention: Device: Endoscopic bipolar radiofrequency probe (ENDOHPB)
12 Recruiting Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Endometrial Papillary Serous Carcinoma;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Gastrointestinal Carcinoid Tumor;   Ovarian Carcinosarcoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Papillary Serous Carcinoma;   Pancreatic Alpha Cell Adenoma;   Pancreatic Alpha Cell Carcinoma;   Pancreatic Beta Islet Cell Adenoma;   Pancreatic Beta Islet Cell Carcinoma;   Pancreatic Delta Cell Adenoma;   Pancreatic Delta Cell Carcinoma;   Pancreatic G-cell Adenoma;   Pancreatic G-cell Carcinoma;   Pancreatic Polypeptide Tumor;   Pulmonary Carcinoid Tumor;   Recurrent Adult Primary Liver Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Regional Gastrointestinal Carcinoid Tumor;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma;   Uterine Carcinosarcoma
Interventions: Drug: temsirolimus;   Biological: bevacizumab
13 Recruiting Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Condition: Colorectal Cancer
Interventions: Drug: celecoxib;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Other: placebo
14 Recruiting Ph I Dose Escalation Study of Antibody-drug Conjugate IMMU-132 in Patients With Advanced Epithelial Cancers
Conditions: Advanced Epithelial Cancers;   Ovarian Cancer;   Prostate Cancer;   Lung Cancer;   Breast Cancer;   Gastric Cancer;   Colorectal Cancer;   Pancreatic Cancer;   Hepatocellular Cancer
Intervention: Drug: IMMU-132
15 Recruiting Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
Conditions: Anal Cancer;   Neoplasm of Uncertain Malignant Potential;   Nonneoplastic Condition;   Precancerous Condition
Interventions: Other: clinical observation;   Procedure: infrared photocoagulation therapy
16 Recruiting Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Conditions: Breast Cancer;   Colon Cancer;   Prostate Cancer;   Lung Cancer
Intervention: Genetic: PCR/PCR/LDR Strategy
17 Recruiting Spectroscopy With Surface Coils and Decoupling
Conditions: Adrenal Cortical Cancer;   Brain Cancer;   Breast Cancer;   CNS Cancer;   Colon Cancer;   HEENT Cancer;   Hodgkin's Disease;   Kaposi's Sarcoma;   Liver Cancer;   Lung Cancer;   Non-Hodgkin's Lymphoma;   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Rectal Cancer;   Renal Cancer;   Sarcoma;   Squamous Cell Carcinoma;   Thyroid Cancer
Interventions: Device: Proton-decoupled 31P MRS at 1.5T;   Device: 1H Spectroscopy at 1.5T and 3T
18 Recruiting Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma
Condition: Gastric Cancer
Interventions: Procedure: Roux-en-Y pouch reconstruction (RYP);   Procedure: conventional Roux-en-Y reconstruction (RYC)

Indicates status has not been verified in more than two years